


Wolff Henry Ward Top Holdings  

































WhaleWisdom









Search All
Search 13F Filers Only
Search SEC Filer
Search Stocks Only
Search Mgmt Inv. Cos Only
ETFs Only
Search Active




















                      Wolff Henry Ward
                    

•   FREMONT, CA
                      
How do I update this listing?




                                             Wolff Henry Ward is based out of Fremont.    WhaleWisdom has at least 10 insider transactions (Form 3,4,5) in our database for Wolff Henry Ward. 
                                           














Summary
13D/G
Insider (Form 4)



   Create Email Alert
 




×
Email Notification.







                   ***Log In or
                   Sign-up
                   to see more advanced email alert options such as selecting any type of
                   SEC form, multiple filers or classes of filers, and much more.***
                 

                    ...or to simply have an email sent to you whenever we receive a new
                           13F filing from Wolff Henry Ward, enter your
                    email address below and choose 'Submit'.
                

Your email:








Cancel














Contact Info




wolff henry ward


6701 KAISER DRIVE

FREMONT
CA
                                                        
                                                    94555


                                                      Business Phone:
                                                      5109706000
SEC SIC CODE:2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)







Recent SEC Filings




4 filed on 06/19/2017
4 filed on 06/13/2017
4 filed on 12/14/2016
4 filed on 06/20/2016
4 filed on 06/16/2016
4 filed on 12/15/2015
4 filed on 12/09/2015
4 filed on 07/14/2015
4 filed on 06/17/2015
4 filed on 06/12/2015
















Schedule 13D and 13G events since 03/31/2017

Subscription required



 
Form 4 - Non-derivative Insider Transactions Since 03/31/2017
Loading...








Elevate your investments
Try it for free




























 





Insider Trading - Wolff Henry Ward - Form 4 SEC Filings












Home |
Archives |
Products |
About |
Contact |
FAQ |



New User?
Sign Up | 
Sign In









Form 4 Filings


Insider Buys


Significant Buys


Penny StocksInsider Buying


Insider Sales




Insider Buy Sell Ratios


Stock Options


Insider TradingStock Screener


Insider TradingGraph View


Insider Watch





Sec Filings Insider Trading - Wolff Henry Ward





Select Time period: 
1 Month
2 Months
3 Months
6 Months
1 Year
2 Years
3 Years
4 Years
All Data
 

     



google

   



yahoo!



Send this page to:  

Blog
  



Digg

  



Reddit

  



Facebook

  



Stumble

  



del.icio.us








Enter Stock Ticker Symbol or Cik:




Cik Lookup...






Search By Company or Insider Name:







"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch ==>>

What is insider trading>>



Email a friend >>...







Historical filings delayed by 6 months. New user?
Sign Up for real time data.
Existing user?
Sign In

Common stock purchase or sale:



TransactionDate
ReportedDate
Company
Symbol
InsiderRelationship
SharesTraded
AveragePrice
TotalAmount
SharesOwned
Filing




2015-07-10Sale
2015-07-144:46 pm
Sangamo Biosciences Inc
SGMO
Wolff Henry WardExec VP & CFO
12,000
$10
$120,000
205,974(Direct)
View


2015-06-10Sale
2015-06-124:50 pm
Sangamo Biosciences Inc
SGMO
Wolff Henry WardExec VP & CFO
12,000
$12.21
$146,558
211,872(Direct)
View


2015-05-11Sale
2015-05-134:40 pm
Sangamo Biosciences Inc
SGMO
Wolff Henry WardExec VP & CFO
12,000
$13.25
$158,949
213,872(Direct)
View


2015-04-10Sale
2015-04-147:03 pm
Sangamo Biosciences Inc
SGMO
Wolff Henry WardExec VP & CFO
12,000
$15.31
$183,771
214,849(Direct)
View


2015-03-19Sale
2015-03-207:28 pm
Sangamo Biosciences Inc
SGMO
Wolff Henry WardExec VP & CFO
10,000
$18
$180,000
251,972(Direct)
View


2015-03-10Sale
2015-03-128:09 pm
Sangamo Biosciences Inc
SGMO
Wolff Henry WardExec VP & CFO
12,000
$16.68
$200,201
216,849(Direct)
View


2015-03-04Sale
2015-03-067:04 pm
Sangamo Biosciences Inc
SGMO
Wolff Henry WardExec VP & CFO
10,000
$18
$180,000
261,972(Direct)
View


2015-02-10Sale
2015-02-128:14 pm
Sangamo Biosciences Inc
SGMO
Wolff Henry WardExec VP & CFO
12,000
$12.65
$151,750
218,849(Direct)
View




Stock options: Exercise, Award, Grant, Conversion



TransactionDate
ReportedDate
ExercisableExpiration
Company
Symnbol
InsiderRelationship
SharesTraded
ConversionPrice
SharesOwned
Filing




2016-12-12Tax Withholding
2016-12-148:03 pm
N/AN/A
Sangamo Biosciences Inc
SGMO
Wolff Henry WardExec VP & CFO
13,778
$3.05
206,829(Direct)
View


2016-06-17Option Award
2016-06-203:37 pm
N/AN/A
Portola Pharmaceuticals Inc
PTLA
Wolff Henry WardDirector
3,000
$0
6,000(Direct)
View


2016-06-17Option Award
2016-06-203:37 pm
N/A2026-06-17
Portola Pharmaceuticals Inc
PTLA
Wolff Henry WardDirector
6,000
$24.19
6,000(Direct)
View


2016-06-14Option Award
2016-06-164:05 pm
N/A2026-06-13
Calithera Biosciences Inc.
CALA
Wolff Henry WardDirector
11,000
$4.76
11,000(Direct)
View


2015-12-11Tax Withholding
2015-12-155:09 pm
N/AN/A
Sangamo Biosciences Inc
SGMO
Wolff Henry WardExec VP & CFO
6,522
$8.68
221,790(Direct)
View


2015-12-11Tax Withholding
2015-12-155:09 pm
N/AN/A
Sangamo Biosciences Inc
SGMO
Wolff Henry WardExec VP & CFO
6,087
$8.68
221,790(Direct)
View


2015-12-07Option Award
2015-12-094:47 pm
N/AN/A
Sangamo Biosciences Inc
SGMO
Wolff Henry WardExec VP & CFO
37,500
$0
235,372(Direct)
View


2015-12-07Tax Withholding
2015-12-094:47 pm
N/AN/A
Sangamo Biosciences Inc
SGMO
Wolff Henry WardExec VP & CFO
7,060
$9.69
235,372(Direct)
View


2015-12-07Option Award
2015-12-094:47 pm
N/A2025-12-07
Sangamo Biosciences Inc
SGMO
Wolff Henry WardExec VP & CFO
75,000
$9.41
235,372(Direct)
View


2015-07-10Exercise
2015-07-144:46 pm
N/AN/A
Sangamo Biosciences Inc
SGMO
Wolff Henry WardExec VP & CFO
6,102
$3.45
205,974(Direct)
View


2015-07-10Exercise
2015-07-144:46 pm
N/AN/A
Sangamo Biosciences Inc
SGMO
Wolff Henry WardExec VP & CFO
3,898
$3.45
205,974(Direct)
View


2015-07-10Exercise
2015-07-144:46 pm
N/A2018-12-09
Sangamo Biosciences Inc
SGMO
Wolff Henry WardExec VP & CFO
6,102
$3.45
205,974(Direct)
View


2015-07-10Exercise
2015-07-144:46 pm
N/A2018-12-09
Sangamo Biosciences Inc
SGMO
Wolff Henry WardExec VP & CFO
3,898
$3.45
205,974(Direct)
View


2015-06-16Option Award
2015-06-177:21 pm
N/A2025-06-16
Portola Pharmaceuticals Inc
PTLA
Wolff Henry WardDirector
10,000
$44.39
10,000(Direct)
View


2015-06-10Exercise
2015-06-124:50 pm
N/AN/A
Sangamo Biosciences Inc
SGMO
Wolff Henry WardExec VP & CFO
10,000
$3.45
211,872(Direct)
View


2015-06-10Exercise
2015-06-124:50 pm
N/A2018-12-09
Sangamo Biosciences Inc
SGMO
Wolff Henry WardExec VP & CFO
10,000
$3.45
211,872(Direct)
View


2015-06-09Option Award
2015-06-114:51 pm
N/A2025-06-08
Calithera Biosciences Inc.
CALA
Wolff Henry WardDirector
11,000
$7.99
33,000(Direct)
View


2015-05-11Exercise
2015-05-134:40 pm
N/AN/A
Sangamo Biosciences Inc
SGMO
Wolff Henry WardExec VP & CFO
10,000
$3.45
213,872(Direct)
View


2015-05-11Exercise
2015-05-134:40 pm
N/A2018-12-09
Sangamo Biosciences Inc
SGMO
Wolff Henry WardExec VP & CFO
10,000
$3.45
213,872(Direct)
View


2015-04-10Exercise
2015-04-147:03 pm
N/AN/A
Sangamo Biosciences Inc
SGMO
Wolff Henry WardExec VP & CFO
10,000
$3.45
214,849(Direct)
View


2015-04-10Exercise
2015-04-147:03 pm
N/A2018-12-09
Sangamo Biosciences Inc
SGMO
Wolff Henry WardExec VP & CFO
10,000
$3.45
214,849(Direct)
View


2015-03-19Exercise
2015-03-207:28 pm
N/AN/A
Sangamo Biosciences Inc
SGMO
Wolff Henry WardExec VP & CFO
10,000
$14.27
251,972(Direct)
View


2015-03-19Exercise
2015-03-207:28 pm
N/A2017-12-02
Sangamo Biosciences Inc
SGMO
Wolff Henry WardExec VP & CFO
10,000
$14.27
251,972(Direct)
View


2015-03-10Exercise
2015-03-128:09 pm
N/AN/A
Sangamo Biosciences Inc
SGMO
Wolff Henry WardExec VP & CFO
10,000
$3.45
216,849(Direct)
View


2015-03-10Exercise
2015-03-128:09 pm
N/A2018-12-09
Sangamo Biosciences Inc
SGMO
Wolff Henry WardExec VP & CFO
10,000
$3.45
216,849(Direct)
View


2015-03-04Exercise
2015-03-067:04 pm
N/AN/A
Sangamo Biosciences Inc
SGMO
Wolff Henry WardExec VP & CFO
10,000
$14.27
261,972(Direct)
View


2015-03-04Exercise
2015-03-067:04 pm
N/A2017-12-02
Sangamo Biosciences Inc
SGMO
Wolff Henry WardExec VP & CFO
10,000
$14.27
261,972(Direct)
View


2015-02-10Exercise
2015-02-128:14 pm
N/AN/A
Sangamo Biosciences Inc
SGMO
Wolff Henry WardExec VP & CFO
10,000
$3.45
218,849(Direct)
View


2015-02-10Exercise
2015-02-128:14 pm
N/A2018-12-09
Sangamo Biosciences Inc
SGMO
Wolff Henry WardExec VP & CFO
10,000
$3.45
218,849(Direct)
View









    © 2005-2017 SecForm4.Com All rights reserved.
    Archives:
    2017 2016 2015 2014 2013 2012 ... 
    Sun, 23 Jul 2017 08:09:43 -0500
  

    SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
    SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC).
Terms of Use |
    Privacy Statement |
  


















































Henry Ward  Wolff - CEO, founder, businessman - profile

















directorpedia.net - List of CEOs, founders, board members and company directors











Henry Ward  Wolff
Check out list of companies and businesses related to Henry Ward  Wolff. Find out Henry Ward  Wolff address and contact details. View other people related to Henry Ward  Wolff - coworkers, colleagues, companions, etc.
Address:   

C/O SANGAMO BIOSCIENCES INC., STE A-100 POINT RICHMOND TECH CNTR, 501 CANAL BLVD RICHMOND 94804 CA




Companies related to Henry Ward  Wolff
CIKCompany NamePositionCompany Address0001001233SANGAMO THERAPEUTICS, INCExec VP & CFO 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND 94804




Henry Ward  Wolff on the Web
Persons related to Henry Ward  Wolff - SANGAMO THERAPEUTICS, INCNamePositionCityDALE G  ANDOVP, Therapeutic Dev. & CMO SOUTH SAN FRANCISCODALE G  ANDOVP, Therapeutic Dev. & CMO RICHMONDDALE G  ANDORICHMONDDALE G  ANDOVP, Therapeutic Dev. & CMO RICHMONDDALE G  ANDOVP, Therapeutic Dev. & CMO RICHMONDDALE G  ANDOVP, Therapeutic Dev. & CMO RICHMONDDALE G  ANDOVP, Therapeutic Dev. & CMO RICHMONDDALE G  ANDOVP, Therapeutic Dev. & CMO RICHMONDDALE G  ANDOVP, Therapeutic Dev. & CMO RICHMONDPETER  BLUFORDVP, Corporate Development RICHMONDRobert  CareyDirector DEERFIELDCASEY C  CASEVice President, Research RICHMONDCASEY C  CASEVP, Research & Operations RICHMONDPaul B  ClevelandDirector PALO ALTOPaul B  ClevelandDirector RICHMONDPaul B  ClevelandDirector RICHMONDEdward R.  ConnerSenior VP & CMO RICHMONDSTEPHEN GEORGE  DILLYDirector ALAMEDASTEPHEN GEORGE  DILLYDirector RICHMONDSTEPHEN GEORGE  DILLYDirector RICHMONDWILLIAM G  GERBERDirector BOTHELLWILLIAM G  GERBERDirector RICHMONDWILLIAM G  GERBERDirector RICHMONDWILLIAM G  GERBERDirector RICHMONDWILLIAM G  GERBERDirector RICHMONDWILLIAM G  GERBERDirector RICHMONDPhilip D  GregoryVice President, Research & CSO RICHMONDPhilip D  GregorySVP of Research & CSO RICHMONDPhilip D  GregorySVP, Research & CSO RICHMONDPhilip D  GregorySVP of Research & CSO RICHMONDPhilip D  GregoryVice President, Research RICHMONDPhilip D  GregoryVice President, Research RICHMONDPhilip D  GregoryVice President, Research RICHMONDPhilip D  GregoryCSO & Vice President, Research RICHMONDPhilip D  GregorySVP of Research & CSO RICHMONDPhilip D  GregoryCSO & Vice President, Research RICHMONDCurt A.  Herberts IIISr.VP & Chief Business Officer RICHMONDDavid G  IchikawaRICHMONDDavid G  IchikawaSenior VP, Bus. Dev. RICHMONDDavid G  IchikawaSenior VP, Bus. Dev. RICHMONDDavid G  IchikawaSenior VP, Bus. Dev. RICHMONDDavid G  IchikawaSenior VP, Bus. Dev. RICHMONDDavid G  IchikawaSenior VP, Bus. Dev. RICHMONDDavid G  IchikawaSenior VP, Bus. Dev. RICHMONDDavid G  IchikawaSenior VP, Bus. Dev. RICHMONDJON E M  JACOBYDirector LITTLE ROCKJON E M  JACOBYDirector RICHMONDROGER  JEFFSDirector Peter  KolchinskyBOSTONLeRoy C  Kopp10% Owner EDINAEDWARD O  LANPHIER IIDirector RICHMONDEDWARD O  LANPHIER IIRICHMONDEDWARD O  LANPHIER IIPres and Chief Ex Officer RICHMONDEDWARD O  LANPHIER IIPresident & Chief Exec Officer RICHMONDEDWARD O  LANPHIER IIPresident & CEO RICHMONDEDWARD O  LANPHIER IIRICHMONDEDWARD O  LANPHIER IIPresident & CEO RICHMONDEDWARD O  LANPHIER IIPresident & CEO RICHMONDEDWARD O  LANPHIER IIPresident & CEO RICHMONDEDWARD O  LANPHIER IIRICHMONDEDWARD O  LANPHIER IIPresident & CEO RICHMONDEDWARD O  LANPHIER IIPresident and CEO RICHMONDEDWARD O  LANPHIER IIPresident & CEO RICHMONDEDWARD O  LANPHIER IIPresident and CEO RICHMONDEDWARD O  LANPHIER IIPresident & CEO RICHMONDEDWARD O  LANPHIER IIPresident and CEO RICHMONDEDWARD O  LANPHIER IIPresident & CEO RICHMONDEDWARD O  LANPHIER IIRICHMONDEDWARD O  LANPHIER IIPres & Chief Ex Officer RICHMONDJOHN WILLIAM  LARSONDirector RICHMONDJOHN WILLIAM  LARSONDirector RICHMONDJOHN WILLIAM  LARSONDirector RICHMONDJOHN WILLIAM  LARSONDirector RICHMONDJOHN WILLIAM  LARSONDirector RICHMONDJOHN WILLIAM  LARSONDirector RICHMONDJOHN WILLIAM  LARSONDirector RICHMONDJOHN WILLIAM  LARSONDirector RICHMONDJOHN WILLIAM  LARSONDirector RICHMONDJOHN WILLIAM  LARSONDirector RICHMONDJOHN WILLIAM  LARSONDirector RICHMONDMargaret  LiuDirector RICHMONDMargaret  LiuDirector RICHMONDSandy  MacraePresident and CEO RICHMONDSteven J  MentoDirector RICHMONDSteven J  MentoDirector RICHMONDSteven J  MentoDirector RICHMONDSteven J  MentoDirector RICHMONDSteven J  MentoDirector RICHMONDGEOFFREY  NICHOLExecutive Vice President, R&D PRINCETONGEOFFREY  NICHOLExecutive Vice President, R&D RICHMONDGEOFFREY  NICHOLExecutive Vice President, R&D RICHMONDGEOFFREY  NICHOLExecutive Vice President, R&D RICHMONDH STEWART  PARKERDirector SEATTLEH STEWART  PARKERDirector RICHMONDRA Capital Healthcare Fund LPBOSTONRA CAPITAL MANAGEMENT, LLC BOSTONRA CAPITAL MANAGEMENT, LLC BOSTONSaira  RamasastryDirector RICHMONDSaira  RamasastryDirector RICHMONDWILLIAM R  RINGODirector WILLIAM R  RINGODirector RICHMONDWILLIAM R  RINGODirector RICHMONDWILLIAM R  RINGORICHMONDWILLIAM J  RUTTERDirector THOMAS G  WIGGANSDirector RICHMONDTHOMAS G  WIGGANSDirector RICHMONDTHOMAS G  WIGGANSDirector RICHMONDHenry Ward  WolffExec VP & CFO FREMONTHenry Ward  WolffExec VP & CFO RICHMONDHenry Ward  WolffExec VP & CFO RICHMONDHenry Ward  WolffExec VP & CFO RICHMONDHenry Ward  WolffDirector RICHMONDHenry Ward  WolffExec VP & CFO RICHMONDHenry Ward  WolffExec VP & CFO RICHMONDHenry Ward  WolffExec VP & CFO RICHMONDHenry Ward  WolffExec VP & CFO RICHMONDMICHAEL C  WOODDirector MICHAEL C  WOODDirector RICHMONDMICHAEL C  WOODDirector RICHMONDMICHAEL C  WOODDirector RICHMONDKathy  YiSenior VP & CFO RICHMONDJoseph S  ZakrzewskiDirector SOMERSETGREG  ZANTESr Dir., Finance and Admin RICHMONDGREG  ZANTESr Dir., Finance & Admin RICHMONDGREG  ZANTESr. Director Finance & Admin RICHMONDGREG  ZANTEVP, Finance & Administration RICHMONDGREG  ZANTEVice President, Fin. & Admin. RICHMONDGREG  ZANTEVice President, Fin. & Admin. RICHMONDGREG  ZANTEVP, Finance & Administration RICHMOND












 









CALA Henry Ward Wolff Insider Trades for Calithera Biosciences Inc.


































Bulletin






Investor Alert





















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































Calithera Biosciences Inc.

                  NASDAQ: CALA
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

Calithera Biosciences Inc.



After Hours
 --Quotes are delayed by 20 min
Jul 21, 2017, 4:33 p.m.


CALA

/quotes/zigman/38214385/composite


$
15.55




Change

-0.0031
-0.02%

Volume
Volume 14,030
Quotes are delayed by 20 min








/quotes/zigman/38214385/composite
Previous close

$
			15.85
		


$
				15.55
			
Change

-0.30
-1.89%





Day low
Day high
$15.20
$15.95










52 week low
52 week high

            $2.20
        

            $20.05
        


















Insider Activity


Individual




Henry Ward Wolff



Mr. Henry W. Wolff is on the Board of Directors at Calithera Biosciences, Inc. and Portola Pharmaceuticals, Inc. Mr. Wolff was previously employed as an Independent Director by MAP Pharmaceuticals, Inc., Chief Financial Officer & Executive Vice President by Sangamo Therapeutics, Inc., Chief Financial Officer & Senior VP-Finance by Nuvelo, Inc., Chief Financial Officer & SVP-Finance by Abgenix, Inc., Chief Financial Officer by QuantumShift, Inc., Chief Financial Officer & Senior Vice President by DoubleTwist, Inc., Chief Financial Officer by Premenos Technology Corp., Executive Director by Russell Reynolds Associates, Inc, Executive Director by Russell Reynolds Associates, Inc., and Senior Audit Manager by Pricewaterhouse LLP. He received his undergraduate degree from the University of California, Berkeley and an MBA from Harvard Business School.



Transactions


Date
Shares
Transaction
Value








        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    











            Officers and Executives
        





Dr. Susan M. Molineaux 
President, Chief Executive Officer & Director




Ms. Stephanie  Wong 
Vice President-Finance




Dr. Mark K. Bennett 
Senior Vice President-Research




Dr. Keith  Orford 
Senior Vice President-Clinical Development




Dr. Eric B. Sjogren 
Senior Vice President-Drug Discovery




Mr. Curtis C. Hecht 
Vice President-Business & Corporate Development




Dr. Christopher J. Molineaux 
Senior Vice President-Development




Ms. Susan  Jones 
Director




Ms. Jennifer Isacoff McNealey 
Vice President-Investor Relations & Strategy




Dr. Hagit  Glickman 
Head-People & Culture




Dr. Sunil  Agarwal 
Independent Director




Mr. Henry Ward Wolff 
Independent Director




Dr. Jonathan  Drachman 
Independent Director




Dr. Deepa R. Pakianathan 
Independent Director




Ms. Jean M. George 
Independent Director









Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/59386294/composite JNUG-5.94%


/quotes/zigman/65801738/composite TLT+1.11%


X




Powered by














Log In




9:09 AM EDT
July 23, 2017


/marketstate/country/us
New York

	Closed


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
9:00aAlphabet earnings: A $2.74 billion hit for Google, potential YouTube results for investors
8:40aSurprise: Those ‘great’ companies generally turn out to be meh ... or duds
8:40aThis is how Congress could create a bipartisan health-care bill
8:40a4 fears an AI developer has about artificial intelligence
8:39aEx-health insurance CEO: 5 common but faulty beliefs about paying for health care
8:39aDraining the swamp starts with blowing up health care
8:02aThese 7 highly taxed companies need Congress to finally act on tax reform
8:02aBeyond Tesla: 7 stocks driving the autonomous car revolution
7:55aFifty years after the riots, Detroit is finally rising out of the devastation
7:00aYour Next Online Order Could Be Picked Out by a Robot
6:00a4 costly mistakes people make when buying cars
5:00aWhat’s a cameo – like Ed Sheeran on Game of Thrones – actually worth?
5:12pTrump says he has ‘complete power to pardon’
5:08pLawmakers reach deal on Russia sanctions bill: reports
5:00pAlphabet earnings: A $2.74 billion hit for Google, potential YouTube results for investors
3:30pYou can date someone who looks just like Donald Trump with this new online service 
3:29pWant to buy happiness? Splurge on these 5 things
3:28pThis is what people really buy when they emotionally overspend (hint: it’s not designer clothes)
2:40pJohn McCain is a war hero — but think twice before saying he’s ‘battling’ cancer 
2:38pThe dark side of cruises
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,580.07

-31.71
-0.15%





nasdaq

/quotes/zigman/12633936/realtime
6,387.75

-2.25
-0.04%





s&p 500

/quotes/zigman/3870025/realtime
2,472.54

-0.91
-0.04%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15





























































Sangamo Therapeutics Inc (SGMO) Exec VP & CFO Wolff Henry Ward's Insider Stock Buys and Sells 



























Home




 Homepage


 Membership Levels


 Membership Data Coverage


 Complete Stock List


 Founder's Message


 The Book


 FREE Trial






Screeners


Value Screens 


 All-In-One Screener


 Industry Overview


 Ben Graham Net-Net


 Undervalued Predictable


 Buffett-Munger Screener


 Magic Formula (Greenblatt)


 Historical Low P/S List


 Historical Low P/B List


 Peter Lynch Screen


 High Short Interest


 52-Week/3Y/5Y Lows


 52-Week/3Y/5Y Highs


 Predictable Companies


 S&P 500 Grid


 Dividend Stocks


 Spin Off List




Downloads | Tools


  Excel Add-In GURUF


 Manual of Stocks™


 Download Financial Data


 Download Guru Portfolios


 Download Stock PDFs


 Download Insider Data


  API


 Mobile App




Strategies


 Performances


 Buffett-Munger


 Undervalued Predictable


 Low P/S


 Low P/B


 Broadest Owned


 Most Weighted






Gurus




 Latest Guru Picks


 Real Time Picks


 List of Gurus (Personalize)


 Gurus Portfolios


 Scoreboard


 Top 10 Holdings View


 Sector Picks


 International Picks


 Aggregated Portfolio


 Consensus Picks


 Guru Bargains


 Hot Picks


 Industry Trends


 Geographic Trend


 ETFs


 Options


 European Shorting






Insiders




 All Insiders


 CEO Buys/Sales


 CFO Buys/Sales


 Insider Cluster


 Guru+Insider Double Buys


 Triple Buys/Sales


 Insider Trends


 Canadian Insider


 Dutch Insider






Market


Market Valuation


 Economic Data


 Industry Overview


 Market-Cap/GDP Valuation


 Global Market Valuation


 Shiller P/E


 Shiller P/E By Sectors


 Buffett Assets Allocation




By Country


 USA


 Australia


 Canada


 China


 Germany


 India


 Japan


 UK


 More...






Articles


Articles


 Editor's Picks


 GuruFocus Research


 Value Ideas


 Interviews with Gurus


 Top Ranked


 Value Idea Contest


 Videos


 Following Authors




Submit Articles


 Writers Wanted


 Value Contest Winners


 Submit Articles Online


 My Articles






Conference




 Value Conference


 Speakers


 Location/Venue


 Register


 After Conference Gathering (Free Drinks)






Tutorials




 Tutorials & Webinars


 FAQ


 Contact Us






Log In




 Free Sign-up


 Log In


 7-Day Free Trial 






Subscribe




 Free Trial ($399/Year)


 Refer a Friend & Earn $50














Search
Compare

Search ▾










Get 7-Day Free Trial



My Portfolios▾

Portfolios Overview
Create New Portfolio
Portfolio Contest


My Gurus▾

Quick Browse
Personalize

My Gurus

Premium Gurus 
Premium Plus Investors 





















SummaryCanadian Dutch CEO Buys CFO Buys Insider Cluster Buys Double Buys Triple Buys Data Export Trend  




Saved!




USA

Canada

UK/Ireland

Europe

Asia

Oceania

Latin America

Africa



Currently Selected:



Show All Countries ▾





Purchase to select this region

Purchase $399
USA

OTCPK
NAS
NYSE
ARCA
OTCBB
AMEX
BATS




Purchase to select this region

Purchase $289
Canada

TSXV
TSX
XCNQ




Purchase to select this region

Purchase $269
UK/Ireland

UK




Purchase to select this region

Purchase $399
Europe

Germany
France
Poland
Russia
Sweden
Turkey
Bosnia and Herzegovina
Italy
Luxembourg
Switzerland


Belgium
Greece
Norway
Spain
Denmark
Bulgaria
Netherlands
Romania
Finland
Serbia
Austria
Croatia
Portugal
Slovakia
Cyprus
Macedonia
Slovenia
Ukraine
Hungary
Lithuania
Latvia
Malta
Iceland
Estonia
Czech Republic

All Countries ▾



Purchase to select this region

Purchase $399
Asia

India
Japan
Korea
Thailand
Hongkong
China
Taiwan
Malaysia
Singapore
Israel


Indonesia
Pakistan
Vietnam
Philippines
Sri Lanka
Kuwait
Nepal
Saudi
Jordan
Oman
Iran
Iraq
United Arab Emirates
Kazakhstan
Bahrain

All Countries ▾



Purchase to select this region

Purchase $269
Oceania

Australia
New zealand




Purchase to select this region

Purchase $299
Latin America

Brazil
Mexico
Argentina
Chile
Peru
Columbia
Jamaica
Venezuela
Ecuador




Purchase to select this region

Purchase $249
Africa

South Africa
Egypt
Nigeria
Mauritius
Morocco
Zimbabwe
Kenya
Tunisia
Ghana
Côte d'Ivoire




 Set As Default







Insider Trades


Try Insider Screener



Sangamo Therapeutics Inc (SGMO) Exec VP & CFO Wolff Henry Ward's Insider Stock Buys and SellsTo find out why GuruFocus thinks data on insider trades is interesting, read

Can Aggregated Insider Trading Activities Predict the Market?
Stocks That Both Gurus and Insiders Are Buying
Can Aggregated Insider Trading Activities Predict the Market of Different Sectors?




Filter by:



  Default





Search Insider Trade:




Go




Select to drill down:


All Market CapMicro Cap Small Cap Mid Cap Large Cap Mega Cap S&P 500 Companies All SectorsBasic Materials Consumer Cyclical Financial Services Real Estate Consumer Defensive Healthcare Utilities Communication Services Energy Industrials Technology   Display Those with At Least
100 500 1,000 2,000 5,000 10,000 20,000 50,000 100,000  Shares Display Stocks That are within Please Select 1% 
2% 
3% 
4% 
5% 
8% 
10% 
 of Please Select 52-Week Low3-Year Low5-Year LowReal time insider type:BuySellInsider Sentiment Chart 


 Recent Filings Activity
 

Total Records: 636048   Page:1  2   3   4   5   6   7   8   9   10   LAST (21202) 30 per page ▾ 10 20 2530 50 100



Symbol
Company
Insider
Position
Date
Buy/Sell
Shares
Trade Price ($)
Cost ($1000)
Price ChangeSince Trade (%)
Yield (%)
P/E
Market Cap ($M)
Details

SGMOSangamo Therape...Wolff Henry WardExec VP & CFO2015-07-13Sell12,000$10120-5
0.000.00792.670 Link

SGMOSangamo Therape...Wolff Henry WardExec VP & CFO2015-06-10Sell12,000$12.21146.52-22.19
0.000.00792.670 Link

SGMOSangamo Therape...Wolff Henry WardExec VP & CFO2015-05-11Sell12,000$13.25159-28.3
0.000.00792.670 Link

SGMOSangamo Therape...Wolff Henry WardExec VP & CFO2015-04-10Sell12,000$15.31183.72-37.95
0.000.00792.670 Link

SGMOSangamo Therape...Wolff Henry WardExec VP & CFO2015-03-19Sell10,000$18180-47.22
0.000.00792.670 Link

SGMOSangamo Therape...Wolff Henry WardExec VP & CFO2015-03-10Sell12,000$16.68200.16-43.05
0.000.00792.670 Link

SGMOSangamo Therape...Wolff Henry WardExec VP & CFO2015-03-04Sell10,000$18180-47.22
0.000.00792.670 Link

SGMOSangamo Therape...Wolff Henry WardExec VP & CFO2015-02-10Sell12,000$12.65151.8-24.9
0.000.00792.670 Link

SGMOSangamo Therape...Wolff Henry WardExec VP & CFO2014-11-10Sell2,000$11.3722.74-16.45
0.000.00792.670 Link

SGMOSangamo Therape...Wolff Henry WardExec VP & CFO2014-10-10Sell2,000$10.120.2-5.94
0.000.00792.670 Link

SGMOSangamo Therape...Wolff Henry WardExec VP & CFO2014-09-10Sell2,000$12.3124.62-22.83
0.000.00792.670 Link

SGMOSangamo Therape...Wolff Henry WardExec VP & CFO2014-08-11Sell10,000$14.17141.7-32.96
0.000.00792.670 Link

SGMOSangamo Therape...Wolff Henry WardExec VP & CFO2014-07-10Sell15,000$13.26198.9-28.36
0.000.00792.670 Link

SGMOSangamo Therape...Wolff Henry WardExec VP & CFO2014-06-10Sell15,000$15.62234.3-39.18
0.000.00792.670 Link

SGMOSangamo Therape...Wolff Henry WardExec VP & CFO2014-05-12Sell15,000$12.85192.75-26.07
0.000.00792.670 Link

SGMOSangamo Therape...Wolff Henry WardExec VP & CFO2014-04-10Sell15,000$15.72235.8-39.57
0.000.00792.670 Link

SGMOSangamo Therape...Wolff Henry WardExec VP & CFO2014-03-10Sell10,000$22.31223.1-57.42
0.000.00792.670 Link

SGMOSangamo Therape...Wolff Henry WardExec VP & CFO2014-02-10Sell10,000$19.26192.6-50.67
0.000.00792.670 Link

SGMOSangamo Therape...Wolff Henry WardExec VP & CFO2014-01-10Sell10,000$18.69186.9-49.17
0.000.00792.670 Link

SGMOSangamo Therape...Wolff Henry WardExec VP & CFO2013-12-10Sell10,000$11.97119.7-20.63
0.000.00792.670 Link

SGMOSangamo Therape...Wolff Henry WardExec VP & CFO2013-11-13Sell10,000$10100-5
0.000.00792.670 Link

SGMOSangamo Therape...Wolff Henry WardExec VP & CFO2013-10-10Sell10,000$11.28112.8-15.78
0.000.00792.670 Link

SGMOSangamo Therape...Wolff Henry WardExec VP & CFO2013-09-10Sell10,000$10.86108.6-12.52
0.000.00792.670 Link

SGMOSangamo Therape...Wolff Henry WardExec VP & CFO2013-08-13Sell10,000$10100-5
0.000.00792.670 Link

SGMOSangamo Therape...Wolff Henry WardExec VP & CFO2013-07-17Sell10,000$10100-5
0.000.00792.670 Link

SGMOSangamo Therape...Wolff Henry WardExec VP & CFO2013-04-10Sell10,000$10100-5
0.000.00792.670 Link

SGMOSangamo Therape...Wolff Henry WardExec VP & CFO2013-02-28Sell10,000$10100-5
0.000.00792.670 Link

SGMOSangamo Therape...Wolff Henry WardExec VP & CFO2013-01-23Sell10,000$10100-5
0.000.00792.670 Link
Total Records: 636048   Page:1  2   3   4   5   6   7   8   9   10   LAST (21202) 30 per page ▾ 10 20 2530 50 100Add this list into my watchlist/portfolio:

1. Add or remove tickers (Comma separated, up to 500 symbols)
SGMO





2. Select destination portfolioYou need to log in to proceed
3. Click the button to finish
 


Related News and Stories: S: Sprint Corp (S) Files 10-K for the Fiscal Year Ended on March 31, 2017 05-26-2017S: Daniel Loeb Comments on Sprint 11-02-2016S: Sprint Should Continue to Run Higher 10-21-2016S: Note of S 08-02-2016S: Is Sprint’s 1st-Quarter Performance Repeatable? 07-26-2016S: comment on S 06-11-2016S: stocknote 09-16-2015S: OIL 06-05-2015S: comment on S 04-10-2015S: comment on S 03-02-2015S: stocknote 11-16-2014S: comment on S 11-16-2014S: Mason Morfit of ValueAct Capital - Activist Investing (Background, Impact and the Players) 03-14-2014S: Dodge & Cox Comments on Sprint 08-22-2013S: What Is Hedge Fund Legend Leon Cooperman Buying Today? 06-19-2013 Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company. 


 



Select portfolio(s):








                        Create a new portfolio



Why you are interested?



            Your selection and notes will be stored in your portfolio.
        


Login to add portfolio















Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
                    | Earn affiliate commissions by embedding GuruFocus Charts

                                                GuruFocus Affiliate Program: Earn up to $400 per referral.  ( Learn More) 













Home  About   Jobs    Advertise    Site Map    Term of Use    Privacy Policy     RSS    Mobile App     Email Alerts    Referral Program    Affiliate Program    FAQ    Contact Us
                               

                © 2004-2017                GuruFocus.com, LLC. All Rights Reserved.
            


                    Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC.



                    Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.


















GF Chat {{numOfNotice}}




























×
Manage BookMarks





Close








FEEDBACK














Stock Screener - Yahoo FinanceHomeMailFlickrTumblrNewsSportsFinanceCelebrityAnswersGroupsMobileMoreYahooSearchSearch0U.S. Markets closedS&P 5002,472.54-0.91 (-0.04%)Dow 3021,580.07-31.71 (-0.15%)Insider TransactionsDefault CriteriaInsider & Restricted Shareholder Transactions1-7 of 7 resultsResults were generated a few mins ago. Pricing data is updated frequently. Currency in USDSymbolDateSharesProceedsTransaction DetailsPTLA2017-06-153,000N/AAcquisition (Non Open Market) at $0.00 per share.PTLA2016-06-163,000N/AAcquisition (Non Open Market) at $0.00 per share.SGMO2015-12-1113,778$42,023.00Disposition (Non Open Market) at $3.05 per share.SGMO2015-12-116,087$53,000.00Disposition (Non Open Market) at $8.68 - $8.68 per share.SGMO2015-12-106,522$57,000.00Disposition (Non Open Market) at $8.68 - $8.68 per share.SGMO2015-12-0737,500N/AAcquisition (Non Open Market) at $0.00 per share.SGMO2015-12-067,060$68,000.00Disposition (Non Open Market) at $9.69 - $9.69 per share.Why it might be ‘dangerous’ for IBM to turn itself around: professorYahoo Finance2 Dudes in a Car: Blissing out in the Lincoln ContinentalYahoo FinanceWhat it's like to ship yourself overnight on Cabin's sleep pod busTechCrunchYahoo Small BusinessData DisclaimerHelpSuggestionsPrivacyAbout Our AdsTerms (Updated)





   H. Wolff | Sangamo BioSciences , Inc. | ZoomInfo.com


Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft













Robot Check













Enter the characters you see below
Sorry, we just need to make sure you're not a robot. For best results, please make sure your browser is accepting cookies.










Type the characters you see in this image:








Try different image











Continue shopping











Conditions of Use




Privacy Policy


          © 1996-2014, Amazon.com, Inc. or its affiliates
          











Robot Check













Enter the characters you see below
Sorry, we just need to make sure you're not a robot. For best results, please make sure your browser is accepting cookies.










Type the characters you see in this image:








Try different image











Continue shopping











Conditions of Use




Privacy Policy


          © 1996-2014, Amazon.com, Inc. or its affiliates
          











Robot Check













Enter the characters you see below
Sorry, we just need to make sure you're not a robot. For best results, please make sure your browser is accepting cookies.










Type the characters you see in this image:








Try different image











Continue shopping











Conditions of Use




Privacy Policy


          © 1996-2014, Amazon.com, Inc. or its affiliates
          







